J. Scott Wolchko - President and CEO, Director at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
FATE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

J. Scott Wolchko - trading volume in the past year for Fate Therapeutics Inc

Holdings reported by J. Scott Wolchko for Fate Therapeutics Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 371,248 $1.62 M $4.37 Jan 9, 2024 Direct
Stock Option (Right to Buy) 500,000 $1.37 M $2.73 Feb 1, 2024 Direct Common Stock

Transactions reported by J. Scott Wolchko for Fate Therapeutics Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership